Lifecore Biomedical Inc (NAS:LFCR)
$ 7.6 0.57 (8.11%) Market Cap: 279.88 Mil Enterprise Value: 411.23 Mil PE Ratio: 152.00 PB Ratio: 0 GF Score: 69/100

Q1 2025 Lifecore Biomedical Inc Earnings Call Transcript

Oct 04, 2024 / 12:30PM GMT
Release Date Price: $5.38 (+14.35%)
Operator

Good morning, and thank you for joining Lifecore's fiscal 2025 first quarter earnings call. During the presentation, all participants will be in a listen-only mode. Now I'd like to turn the call over to Stephanie Diaz, Manager of Investor Relations for Lifecore.

Stephanie Diaz
Vida Strategic Partners - Investor Relations

Good morning, and thank you for joining us today to discuss Lifecore Biomedical's first quarter fiscal 2025 earnings results. In the call today from Lifecore are Paul Josephs, President and Chief Executive Officer; and Ryan Lake, Chief Financial Officer.

Before we begin today, I'd like to remind everyone that certain statements made in the course of this conference call contain forward-looking statements. It is important to note that the forward-looking statements made during this call reflect management's judgment and analysis only as of today, October 4, 2024, and the company's actual results could differ materially from those projected in such forward-looking statements.

For a more thorough discussion of the risks and

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot